Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-03-12 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise +883 8,775.36
2019-03-12 Nazzi Gianfranco EVP, Growth Markets Commercial Sale −325 $15.69 $5K 8,450.36
2019-03-12 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise · Restricted Share Units −883 0
2019-03-12 Griffin Deborah A Chief Accounting Officer Option exercise +953 953
2019-03-12 Griffin Deborah A Chief Accounting Officer Sale −953 $15.67 $15K 0
2019-03-12 Griffin Deborah A Chief Accounting Officer Option exercise · Restricted Share Units −953 0
2019-03-12 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise +1,191 9,248.7
2019-03-12 Dethlefs Sven EVP Global Marketing&Portfolio Sale −647 $15.67 $10K 8,601.7
2019-03-12 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise · Restricted Share Units −1,191 0
2019-03-12 Daniell Richard Exec. VP, European Commercial Option exercise +715 715
2019-03-12 Daniell Richard Exec. VP, European Commercial Sale −715 $15.69 $11K 0
2019-03-12 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −715 0
2019-03-04 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +41,791 41,791
2019-03-04 Schultz Kare President and CEO Grant or award · Restricted Share Units +179,104 179,104
2019-03-04 Sabag Mark EVP, Global Human Resources Grant or award · Restricted Share Units +47,761 47,761
2019-03-04 O'Grady Brendan P. EVP, North America Commercial Grant or award · Restricted Share Units +56,716 56,716
2019-03-04 Nazzi Gianfranco EVP, Growth Markets Commercial Grant or award · Restricted Share Units +38,805 38,805
2019-03-04 McClellan Michael James EVP, Chief Financial Officer Grant or award · Restricted Share Units +50,746 50,746
2019-03-04 Griffin Deborah A Chief Accounting Officer Grant or award · Restricted Share Units +19,321 19,321
2019-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +56,716 56,716

Page 66 of 76 · 1,517 trades